Information Journal Paper
APA:
Copy. (2018). TIGIT: a novel immunotherapy target moving from bench to bedside. CANCER IMMUNOLOGY, IMMUNOTHERAPY, 67(11), 1659-1667. SID. https://sid.ir/paper/748523/en
Vancouver:
Copy. TIGIT: a novel immunotherapy target moving from bench to bedside. CANCER IMMUNOLOGY, IMMUNOTHERAPY[Internet]. 2018;67(11):1659-1667. Available from: https://sid.ir/paper/748523/en
IEEE:
Copy, “TIGIT: a novel immunotherapy target moving from bench to bedside,” CANCER IMMUNOLOGY, IMMUNOTHERAPY, vol. 67, no. 11, pp. 1659–1667, 2018, [Online]. Available: https://sid.ir/paper/748523/en